On Jun. 22, 2008, National Cancer Institute researchers announced that cells from a blood-borne cancer called multiple myeloma rely on the activity of a single protein, called IRF4, for the activation of a wide range of genes responsible for cell survival and spread.

Blocking the production of this protein can be strikingly effective in eliminating cancer cells in laboratory models of multiple myeloma. The results were published results in Nature.